DJIA 17,678.23 -40.31 -0.23%
NASDAQ 4,863.36 -13.16 -0.27%
S&P 500 2,056.15 -4.90 -0.24%
market minute promo

24.49 24.49 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IDIX $24.49 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $3.7B
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.97

Sector

Healthcare

Industry

Drug Makers

Idenix Pharmaceuticals, Inc. (IDIX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe. Website: http://www.idenix.com/

News & Commentary

Biotech M&A: Do We Need a New Driver?

Hepatitis C acquisitions like we've seen from Gilead, Bristol-Myers Squibb, and Merck can't last forever.

What Investors Are Watching For In Regulus Therapeutics' Next Data Release

The New Baupost Biotech Picks

Why Did Baupost Double Its Stake In Keryx Biopharmaceuticals?

10 Nasdaq stocks with returns of at least 240% in 2014

Buying Biotech

Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN)

UPDATE: Deutsche Bank Initiates Coverage On Merck

Prem Watsa Buys 4 New Stocks

Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential

Merck: Should You Buy It?

See More IDIX News...

IDIX's Top Competitors

IDIX $24.49 (0.00%)
Current stock: IDIX
AMGN $160.55 (-0.04%)
Current stock: AMGN
GILD $101.08 (1.22%)
Current stock: GILD
BIIB $429.09 (-0.59%)
Current stock: BIIB